Novo Nordisk and Hims & Hers have come to a mutual agreement, choosing collaboration over conflict by dropping…
Shares of Hims & Hers Health (NYSE: HIMS) experienced a significant surge in value following an agreement with…
Parnassus Investments, an investment management firm, recently released its “Parnassus Value Equity Fund” third-quarter 2025 investor letter. The…
The recent deal struck by the Trump administration to increase access to and decrease the cost of weight…
The Trump administration made a significant announcement on Thursday regarding a deal with Novo Nordisk and Eli Lilly…
Novo Nordisk, a leading pharmaceutical company known for its Wegovy obesity drug, has recently faced challenges in the…
Novo Nordisk and Pfizer are currently engaged in a fierce bidding war over the acquisition of obesity biotech…
The Trump administration is reportedly in the final stages of negotiations with pharmaceutical giants Eli Lilly and Novo…
Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Merger Agreement In a recent development, Pfizer has taken…
Metsera Emerges as the Hottest Contender in the Obesity Drug Market Metsera, a New York-based biotech company, has…
We have recently featured a piece titled 10 Major Players With Significant Gains; 6 Reach All-Time Highs. Among…
Novo Nordisk is significantly enhancing its footprint in the U.S. manufacturing industry with plans for facility expansion. The…
Sign in to your account